title: Favorable outcome of primary CNS anaplastic large cell lymphoma in an immunocompetent patient.
abstract: A 9-year-old immunocompetent male patient with primary central nervous system anaplastic large cell lymphoma was treated with 5 cycles of intensive chemotherapy including high-dose Ara-C, high-dose methotrexate, etoposide, and carmustine along with intraventricular chemotherapy followed by high-dose thiotepa and carboplatin with autologous peripheral blood hematopoietic stem cell transplantation. He received radiotherapy as the final therapy and has remained in remission for 26 months off therapy.
authors.affiliation: Section of Hematology/Oncology, Department of Pediatrics, New York Medical College, New York, NY 10595, USA. mehmet_ozkaynak@nymc.edu
authors.forename: Mehmet Fevzi
authors.initials: MF
authors.lastname: Ozkaynak
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000628:therapy*; D002648:Child; D006801:Humans; D007121:Immunocompetence; D017728:Lymphoma, Large-Cell, Anaplastic / Q000628:therapy*; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation; D012074:Remission Induction / Q000379:methods; D014182:Transplantation, Autologous; D016896:Treatment Outcome